Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
D Hagin, T Freund, M Navon, T Halperin, D Adir… - Journal of Allergy and …, 2021 - Elsevier
Background In mid-December 2020, Israel started a nationwide mass vaccination campaign
against coronavirus disease 2019 (COVID-19). In the first few weeks, medical personnel …
against coronavirus disease 2019 (COVID-19). In the first few weeks, medical personnel …
Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects
Background Data on the safety and efficacy of coronavirus disease 2019 (COVID-19)
vaccination in people with a range of primary immunodeficiencies (PIDs) are lacking …
vaccination in people with a range of primary immunodeficiencies (PIDs) are lacking …
Immunizing the imperfect immune system: Coronavirus disease 2019 vaccination in patients with inborn errors of immunity
JR Durkee-Shock, MD Keller - Annals of Allergy, Asthma & Immunology, 2022 - Elsevier
Objective To update clinicians on current evidence regarding the immunogenicity and safety
of coronavirus disease 2019 (COVID-19) vaccines in patients with inborn errors of immunity …
of coronavirus disease 2019 (COVID-19) vaccines in patients with inborn errors of immunity …
Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity
OM Delmonte, JRE Bergerson, PD Burbelo… - Journal of Allergy and …, 2021 - Elsevier
Background SARS-CoV-2 vaccination is recommended in patients with inborn errors of
immunity (IEIs); however, little is known about immunogenicity and safety in these patients …
immunity (IEIs); however, little is known about immunogenicity and safety in these patients …
[HTML][HTML] Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies
D Amodio, A Ruggiero, M Sgrulletti, C Pighi… - Frontiers in …, 2021 - frontiersin.org
Mass SARS-Cov-2 vaccination campaign represents the only strategy to defeat the global
pandemic we are facing. Immunocompromised patients represent a vulnerable population at …
pandemic we are facing. Immunocompromised patients represent a vulnerable population at …
[HTML][HTML] Coronavirus disease 2019 in patients with inborn errors of immunity: an international study
Background There is uncertainty about the impact of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection in individuals with rare inborn errors of immunity (IEI) …
coronavirus 2 (SARS-CoV-2) infection in individuals with rare inborn errors of immunity (IEI) …
Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies
M Zendt, FA Bustos Carrillo, S Kelly, T Saturday… - Science …, 2023 - science.org
Research on coronavirus disease 2019 vaccination in immune-deficient/disordered people
(IDP) has focused on cancer and organ transplantation populations. In a prospective cohort …
(IDP) has focused on cancer and organ transplantation populations. In a prospective cohort …
[HTML][HTML] Risk factors for severe COVID-19 and hospital admission in patients with inborn errors of immunity-results from a multicenter nationwide study
T Milota, M Sobotkova, J Smetanova… - Frontiers in …, 2022 - frontiersin.org
Despite the progress in the understanding how COVID-19 infection may impact
immunocompromised patients, the data on inborn errors of immunity (IEI) remain limited and …
immunocompromised patients, the data on inborn errors of immunity (IEI) remain limited and …
[HTML][HTML] Evaluation of humoral and cellular responses in SARS-CoV-2 mRNA vaccinated immunocompromised patients
M Oyaert, MA De Scheerder, S Van Herrewege… - Frontiers in …, 2022 - frontiersin.org
Background Immunocompromised patients are at increased risk of severe COVID-19 and
impaired vaccine response. In this observational prospective study, we evaluated …
impaired vaccine response. In this observational prospective study, we evaluated …
Humoral and cellular immunity and the safety of COVID-19 vaccines: a summary of data published by 21 May 2021
K Xu, L Dai, GF Gao - International Immunology, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) has caused millions of deaths, and serious
consequences to public health, economies and societies. Rapid responses in vaccine …
consequences to public health, economies and societies. Rapid responses in vaccine …